Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.DiaMedica, a Canadian company engaged in developing treatments for type 2 diabetes, has appointed Reginald Bowerman as its new president and CEO.
Subscribe to our email newsletter
With the appointment of Mr Bowerman, Rick Pauls is stepping down as president and CEO of DiaMedica. Mr Pauls will continue to serve as chairman of the board of directors and work closely with Mr Bowerman during the transition.
Mr Bowerman has spent the past 23 years in various roles in the pharmaceutical industry, most recently as vice president of commercial operations at MGI Pharma.
Mr Pauls said: “Mr Bowerman’s long track record of commercial success, exceptional leadership, interpersonal and organizational skills, along with a diverse industry background in the pharmaceutical sector will guide DiaMedica as we continue to develop into a world-class biopharmaceutical company.”